Loading...
Combination of Olanzapine and Samidorphan Has No Clinically Significant Effect on the Pharmacokinetics of Lithium or Valproate
BACKGROUND AND OBJECTIVE: Olanzapine is an atypical antipsychotic indicated for the treatment of schizophrenia and, either as monotherapy or as an adjunct to lithium or valproate, for bipolar I disorder. Multiple daily doses of olanzapine do not affect the pharmacokinetics of lithium or valproate; t...
Na minha lista:
| Udgivet i: | Clin Drug Investig |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer International Publishing
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6962313/ https://ncbi.nlm.nih.gov/pubmed/31584140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-019-00860-y |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|